Conclusion: Given the knowledge gap under which biosimilars are developed, data to establish biosimilarity should go beyond a simple comparability exercise.
Read More: http://informahealthcare.com/doi/abs/10.1185/03007995.2012.686902
Read More: http://informahealthcare.com/doi/abs/10.1185/03007995.2012.686902
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.